Selected research
Industry Research
Corticosteroid Medication Industry Research Report 2026
Market perspective
The global Corticosteroid Medication market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Corticosteroid Medication is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Corticosteroid Medication is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Corticosteroid Medication is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Corticosteroid Medication include Zhejiang Xianju Pharmaceutical Co.,Ltd, Yangzi River Pharmaceutical Group, Shandong Xinhua Pharmaceutical Company Limited, Sanofi, Johnson & Johnson, Novartis, Merck, Tianjin Tianyao Pharmaceuticals Co., Ltd. and Pfizer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Corticosteroid Medication market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Corticosteroid Medication Market by Company
Zhejiang Xianju Pharmaceutical Co.,Ltd
Yangzi River Pharmaceutical Group
Shandong Xinhua Pharmaceutical Company Limited
Sanofi
Johnson & Johnson
Novartis
Merck
Tianjin Tianyao Pharmaceuticals Co., Ltd.
Pfizer
GSK
Bayer
AstraZeneca
Sumitomo
LEO Pharma
Cipla
Abbott Laboratories
Corticosteroid Medication Segment by Type
Injections
Tablets
Eye Drops
Lotions, Creams, Ointments, or Gels
Capsules
Nasal or Mouth Sprays
Corticosteroid Medication Segment by Application
Clinic
Hospital
Pharmacy
Corticosteroid Medication Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Corticosteroid Medication market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Corticosteroid Medication and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Corticosteroid Medication.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Corticosteroid Medication manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Corticosteroid Medication by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Corticosteroid Medication in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Injections
- Tablets
- Eye Drops
- Lotions, Creams, Ointments, or Gels
- Capsules
- Nasal or Mouth Sprays
Applications
- Clinic
- Hospital
- Pharmacy
Companies covered
- Zhejiang Xianju Pharmaceutical Co.,Ltd
- Yangzi River Pharmaceutical Group
- Shandong Xinhua Pharmaceutical Company Limited
- Sanofi
- Johnson & Johnson
- Novartis
- Merck
- Tianjin Tianyao Pharmaceuticals Co., Ltd.
- Pfizer
- GSK
- Bayer
- AstraZeneca
- Sumitomo
- LEO Pharma
- Cipla
- Abbott Laboratories
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Corticosteroid Medication Market Size (2021-2032)
- 2.2.2 Global Corticosteroid Medication Sales (2021-2032)
- 2.2.3 Global Corticosteroid Medication Market Average Price (2021-2032)
- 2.3 Corticosteroid Medication by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Injections
- 2.3.3 Tablets
- 2.3.4 Eye Drops
- 2.3.5 Lotions, Creams, Ointments, or Gels
- 2.3.6 Capsules
- 2.3.7 Nasal or Mouth Sprays
- 2.4 Corticosteroid Medication by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Clinic
- 2.4.3 Hospital
- 2.4.4 Pharmacy
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Corticosteroid Medication Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Corticosteroid Medication Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Corticosteroid Medication Revenue of Manufacturers (2021-2026)
- 3.4 Global Corticosteroid Medication Average Price by Manufacturers (2021-2026)
- 3.5 Global Corticosteroid Medication Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Corticosteroid Medication, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Corticosteroid Medication, Product Type & Application
- 3.8 Global Manufacturers of Corticosteroid Medication, Established Date
- 3.9 Global Corticosteroid Medication Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Zhejiang Xianju Pharmaceutical Co.,Ltd
- 4.1.1 Zhejiang Xianju Pharmaceutical Co.,Ltd Company Information
- 4.1.2 Zhejiang Xianju Pharmaceutical Co.,Ltd Business Overview
- 4.1.3 Zhejiang Xianju Pharmaceutical Co.,Ltd Corticosteroid Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Zhejiang Xianju Pharmaceutical Co.,Ltd Corticosteroid Medication Product Portfolio
- 4.1.5 Zhejiang Xianju Pharmaceutical Co.,Ltd Recent Developments
- 4.2 Yangzi River Pharmaceutical Group
- 4.2.1 Yangzi River Pharmaceutical Group Company Information
- 4.2.2 Yangzi River Pharmaceutical Group Business Overview
- 4.2.3 Yangzi River Pharmaceutical Group Corticosteroid Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Yangzi River Pharmaceutical Group Corticosteroid Medication Product Portfolio
- 4.2.5 Yangzi River Pharmaceutical Group Recent Developments
- 4.3 Shandong Xinhua Pharmaceutical Company Limited
- 4.3.1 Shandong Xinhua Pharmaceutical Company Limited Company Information
- 4.3.2 Shandong Xinhua Pharmaceutical Company Limited Business Overview
- 4.3.3 Shandong Xinhua Pharmaceutical Company Limited Corticosteroid Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Shandong Xinhua Pharmaceutical Company Limited Corticosteroid Medication Product Portfolio
- 4.3.5 Shandong Xinhua Pharmaceutical Company Limited Recent Developments
- 4.4 Sanofi
- 4.4.1 Sanofi Company Information
- 4.4.2 Sanofi Business Overview
- 4.4.3 Sanofi Corticosteroid Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Sanofi Corticosteroid Medication Product Portfolio
- 4.4.5 Sanofi Recent Developments
- 4.5 Johnson & Johnson
- 4.5.1 Johnson & Johnson Company Information
- 4.5.2 Johnson & Johnson Business Overview
- 4.5.3 Johnson & Johnson Corticosteroid Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Johnson & Johnson Corticosteroid Medication Product Portfolio
- 4.5.5 Johnson & Johnson Recent Developments
- 4.6 Novartis
- 4.6.1 Novartis Company Information
- 4.6.2 Novartis Business Overview
- 4.6.3 Novartis Corticosteroid Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Novartis Corticosteroid Medication Product Portfolio
- 4.6.5 Novartis Recent Developments
- 4.7 Merck
- 4.7.1 Merck Company Information
- 4.7.2 Merck Business Overview
- 4.7.3 Merck Corticosteroid Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Merck Corticosteroid Medication Product Portfolio
- 4.7.5 Merck Recent Developments
- 4.8 Tianjin Tianyao Pharmaceuticals Co., Ltd.
- 4.8.1 Tianjin Tianyao Pharmaceuticals Co., Ltd. Company Information
- 4.8.2 Tianjin Tianyao Pharmaceuticals Co., Ltd. Business Overview
- 4.8.3 Tianjin Tianyao Pharmaceuticals Co., Ltd. Corticosteroid Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Tianjin Tianyao Pharmaceuticals Co., Ltd. Corticosteroid Medication Product Portfolio
- 4.8.5 Tianjin Tianyao Pharmaceuticals Co., Ltd. Recent Developments
- 4.9 Pfizer
- 4.9.1 Pfizer Company Information
- 4.9.2 Pfizer Business Overview
- 4.9.3 Pfizer Corticosteroid Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Pfizer Corticosteroid Medication Product Portfolio
- 4.9.5 Pfizer Recent Developments
- 4.10 GSK
- 4.10.1 GSK Company Information
- 4.10.2 GSK Business Overview
- 4.10.3 GSK Corticosteroid Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 GSK Corticosteroid Medication Product Portfolio
- 4.10.5 GSK Recent Developments
- 4.11 Bayer
- 4.11.1 Bayer Company Information
- 4.11.2 Bayer Business Overview
- 4.11.3 Bayer Corticosteroid Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Bayer Corticosteroid Medication Product Portfolio
- 4.11.5 Bayer Recent Developments
- 4.12 AstraZeneca
- 4.12.1 AstraZeneca Company Information
- 4.12.2 AstraZeneca Business Overview
- 4.12.3 AstraZeneca Corticosteroid Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 AstraZeneca Corticosteroid Medication Product Portfolio
- 4.12.5 AstraZeneca Recent Developments
- 4.13 Sumitomo
- 4.13.1 Sumitomo Company Information
- 4.13.2 Sumitomo Business Overview
- 4.13.3 Sumitomo Corticosteroid Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Sumitomo Corticosteroid Medication Product Portfolio
- 4.13.5 Sumitomo Recent Developments
- 4.14 LEO Pharma
- 4.14.1 LEO Pharma Company Information
- 4.14.2 LEO Pharma Business Overview
- 4.14.3 LEO Pharma Corticosteroid Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 LEO Pharma Corticosteroid Medication Product Portfolio
- 4.14.5 LEO Pharma Recent Developments
- 4.15 Cipla
- 4.15.1 Cipla Company Information
- 4.15.2 Cipla Business Overview
- 4.15.3 Cipla Corticosteroid Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Cipla Corticosteroid Medication Product Portfolio
- 4.15.5 Cipla Recent Developments
- 4.16 Abbott Laboratories
- 4.16.1 Abbott Laboratories Company Information
- 4.16.2 Abbott Laboratories Business Overview
- 4.16.3 Abbott Laboratories Corticosteroid Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Abbott Laboratories Corticosteroid Medication Product Portfolio
- 4.16.5 Abbott Laboratories Recent Developments
5 Global Corticosteroid Medication Market Scenario by Region
- 5.1 Global Corticosteroid Medication Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Corticosteroid Medication Sales by Region: 2021-2032
- 5.2.1 Global Corticosteroid Medication Sales by Region: 2021-2026
- 5.2.2 Global Corticosteroid Medication Sales by Region: 2027-2032
- 5.3 Global Corticosteroid Medication Revenue by Region: 2021-2032
- 5.3.1 Global Corticosteroid Medication Revenue by Region: 2021-2026
- 5.3.2 Global Corticosteroid Medication Revenue by Region: 2027-2032
- 5.4 North America Corticosteroid Medication Market Facts & Figures by Country
- 5.4.1 North America Corticosteroid Medication Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Corticosteroid Medication Sales by Country (2021-2032)
- 5.4.3 North America Corticosteroid Medication Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Corticosteroid Medication Market Facts & Figures by Country
- 5.5.1 Europe Corticosteroid Medication Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Corticosteroid Medication Sales by Country (2021-2032)
- 5.5.3 Europe Corticosteroid Medication Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Corticosteroid Medication Market Facts & Figures by Country
- 5.6.1 Asia Pacific Corticosteroid Medication Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Corticosteroid Medication Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Corticosteroid Medication Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Corticosteroid Medication Market Facts & Figures by Country
- 5.7.1 South America Corticosteroid Medication Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Corticosteroid Medication Sales by Country (2021-2032)
- 5.7.3 South America Corticosteroid Medication Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Corticosteroid Medication Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Corticosteroid Medication Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Corticosteroid Medication Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Corticosteroid Medication Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Corticosteroid Medication Sales by Type (2021-2032)
- 6.1.1 Global Corticosteroid Medication Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Corticosteroid Medication Sales Market Share by Type (2021-2032)
- 6.2 Global Corticosteroid Medication Revenue by Type (2021-2032)
- 6.2.1 Global Corticosteroid Medication Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Corticosteroid Medication Revenue Market Share by Type (2021-2032)
- 6.3 Global Corticosteroid Medication Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Corticosteroid Medication Sales by Application (2021-2032)
- 7.1.1 Global Corticosteroid Medication Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Corticosteroid Medication Sales Market Share by Application (2021-2032)
- 7.2 Global Corticosteroid Medication Revenue by Application (2021-2032)
- 7.2.1 Global Corticosteroid Medication Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Corticosteroid Medication Revenue Market Share by Application (2021-2032)
- 7.3 Global Corticosteroid Medication Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Corticosteroid Medication Value Chain Analysis
- 8.1.1 Corticosteroid Medication Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Corticosteroid Medication Production Mode & Process
- 8.2 Corticosteroid Medication Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Corticosteroid Medication Distributors
- 8.2.3 Corticosteroid Medication Customers
9 Global Corticosteroid Medication Analyzing Market Dynamics
- 9.1 Corticosteroid Medication Industry Trends
- 9.2 Corticosteroid Medication Industry Drivers
- 9.3 Corticosteroid Medication Industry Opportunities and Challenges
- 9.4 Corticosteroid Medication Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst